SIRPA and neoplasm: Considering the fact that RT-activated Sirpα−/− macrophages possess a highly immunogenic antigen presentation capacity, we have established an in vitro system to demonstrate that Sirpα−/− macrophages may present tumor antigens to specifically activate tumoricidal Tc.